We only have this paper's title and publication details.
Read it at the sourceExperimental treatment combining navitoclax and ym155 with carboplatin effectively reduces tumor growth in ovarian cancer, indicating promising therapeutic options.
Performance of the confirmatory screen
No takes yet. Share an insight, caveat, or question.
Kenny et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: